The Latest Cardiac and Vascular News
The study aims to: Evaluate the safety of alfapump DSR in patients with heart failure Assess the feasibility of alfapump DSR to remove excess sodium and fluid from the body Explore the potential impact of DSR therapy to restore response to diuretics GHENT, Belgium, Jan. 07, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV […]
Fiscal 2020 Second Quarter Highlights Net sales of $70.0 million, flat compared to the prior-year quarter Gross margin increased 140 basis points year over year to 59.3% GAAP loss per share of $0.07; adjusted earnings per share of $0.06 Announces the acquisition of C3 Wave PICC tip location system subsequent to quarter end […]
Issuance of U.S. Patent No. 15217855 Further Bolsters Endonovo’s Intellectual Patent Portfolio Los Angeles, CA, Jan. 07, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDVD / ENDV) (“Endonovo” or the “Company”), today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 15217855, which […]
Grant will fund advanced R&D and incorporation of artificial intelligence (AI) technology to accelerate drug development using Novoheart’s bio-engineered human heart chambers and tissues The resulting advancements expected to increase scale and capabilities of Novoheart’s MyHeart™ Platform and expand commercialization opportunities for Novoheart’s market-leading technologies VANCOUVER, British Columbia, Jan. 07, […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the successful completion of patient enrollment in the aMAZE™ clinical trial. In addition, the company announced that it has received approval from the Food and Drug Administration […]
TEL AVIV, Israel, Jan. 6, 2020 /PRNewswire/ — Vascular Graft Solutions (VGS) announces on the acquisition of several patent families from NEOGRAFT Technologies Inc. which include patents that were previously developed and owned by Kipsbay Medical Inc, a pioneer in the field of venous external stenting and vascular engineering. The patents portfolio, which includes […]
MINNEAPOLIS, Jan. 6, 2020 /PRNewswire/ — Preventice Solutions announced today the appointment of Tom Sheehy as executive vice president (EVP) and chief commercial officer (CCO). In this role, Sheehy will lead the Preventice commercial organization, including sales, marketing and product management. Sheehy joins Preventice from Medtronic, where he recently served as a senior area sales […]
SHEBOYGAN, Wisconsin, Jan. 6, 2020 /PRNewswire/ — Dr. Nalini Rajamannan — a specialist for patients with valvular heart disease in Most Sacred Heart of Jesus Cardiology, Sheboygan, WI — confirms today that patients finally may get answers about whether medical devices placed in their bodies are tested and safe, as the Food and Drug Administration […]
Next-Generation Cardiac Myosin Inhibitor Advances In Clinical Trial Designed to Assess Effects Using Two-Week Dose Titration Schedule SOUTH SAN FRANCISCO, Calif., Jan. 06, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM) has opened to enrollment. REDWOOD-HCM is a Phase 2 clinical […]
Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH) on current standard of care do not achieve LDL cholesterol (LDL-C) goal and remain at increased risk of cardiovascular events1 The Medicines Company submitted the New Drug Application (NDA) for inclisiran to the FDA […]
